DK1307537T3 - Neospora caninum-isolat - Google Patents
Neospora caninum-isolatInfo
- Publication number
- DK1307537T3 DK1307537T3 DK01955123T DK01955123T DK1307537T3 DK 1307537 T3 DK1307537 T3 DK 1307537T3 DK 01955123 T DK01955123 T DK 01955123T DK 01955123 T DK01955123 T DK 01955123T DK 1307537 T3 DK1307537 T3 DK 1307537T3
- Authority
- DK
- Denmark
- Prior art keywords
- neospora caninum
- isolate
- animals
- extracts
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/10—Protozoa; Culture media therefor
- C12N1/105—Protozoal isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/90—Protozoa ; Processes using protozoa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ9056A AUPQ905600A0 (en) | 2000-07-28 | 2000-07-28 | Parasites |
| PCT/AU2001/000908 WO2002010340A1 (en) | 2000-07-28 | 2001-07-27 | $i(neospora caninum) isolate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1307537T3 true DK1307537T3 (da) | 2007-09-03 |
Family
ID=3823114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01955123T DK1307537T3 (da) | 2000-07-28 | 2001-07-27 | Neospora caninum-isolat |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7361359B2 (da) |
| EP (1) | EP1307537B1 (da) |
| AT (1) | ATE362975T1 (da) |
| AU (3) | AUPQ905600A0 (da) |
| CA (1) | CA2415647A1 (da) |
| DE (1) | DE60128569T2 (da) |
| DK (1) | DK1307537T3 (da) |
| ES (1) | ES2287145T3 (da) |
| NZ (1) | NZ523697A (da) |
| PT (1) | PT1307537E (da) |
| WO (2) | WO2002010341A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2319242B1 (es) * | 2005-12-23 | 2009-12-01 | Laboratorios Hipra, S.A. | Aislado avirulento de neospora canimum y sus usos. |
| ES2326770B1 (es) * | 2007-07-13 | 2010-07-26 | Universidad Complutense De Madrid | Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora. |
| US20100192474A1 (en) | 2009-01-30 | 2010-08-05 | Lehigh University | Ultrahard stishovite nanoparticles and methods of manufacture |
| HUE057035T2 (hu) | 2016-10-05 | 2022-04-28 | Zoetis Services Llc | Liofilizálási eljárások, amelyek stabilan dhidratált egysejtûeket eredményeznek, potens élõ vakcinaként történõ alkalmazásra |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO188396A0 (en) * | 1996-08-26 | 1996-09-19 | Insearch Limited | Detection of protozoan parasites |
| DK0841392T3 (da) * | 1996-11-12 | 2004-11-22 | Pfizer | Svækket levende Neospora vaccine |
| KR20010024245A (ko) | 1997-10-20 | 2001-03-26 | 조지 제이. 리코스 | 네오스포라 백신 |
-
2000
- 2000-07-28 AU AUPQ9056A patent/AUPQ905600A0/en not_active Abandoned
-
2001
- 2001-07-06 WO PCT/AU2001/000819 patent/WO2002010341A1/en not_active Ceased
- 2001-07-06 AU AU2001270345A patent/AU2001270345A1/en not_active Abandoned
- 2001-07-27 ES ES01955123T patent/ES2287145T3/es not_active Expired - Lifetime
- 2001-07-27 NZ NZ52369701A patent/NZ523697A/xx not_active IP Right Cessation
- 2001-07-27 PT PT01955123T patent/PT1307537E/pt unknown
- 2001-07-27 EP EP01955123A patent/EP1307537B1/en not_active Expired - Lifetime
- 2001-07-27 AU AU7739001A patent/AU7739001A/xx not_active Withdrawn
- 2001-07-27 CA CA002415647A patent/CA2415647A1/en not_active Abandoned
- 2001-07-27 DE DE60128569T patent/DE60128569T2/de not_active Expired - Lifetime
- 2001-07-27 US US10/332,387 patent/US7361359B2/en not_active Expired - Fee Related
- 2001-07-27 WO PCT/AU2001/000908 patent/WO2002010340A1/en not_active Ceased
- 2001-07-27 AT AT01955123T patent/ATE362975T1/de active
- 2001-07-27 DK DK01955123T patent/DK1307537T3/da active
-
2007
- 2007-10-31 US US11/979,177 patent/US20080107602A1/en not_active Abandoned
- 2007-10-31 US US11/979,176 patent/US20080107645A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7361359B2 (en) | 2008-04-22 |
| AUPQ905600A0 (en) | 2000-08-24 |
| WO2002010341A1 (en) | 2002-02-07 |
| EP1307537B1 (en) | 2007-05-23 |
| ATE362975T1 (de) | 2007-06-15 |
| DE60128569T2 (de) | 2008-01-31 |
| ES2287145T3 (es) | 2007-12-16 |
| CA2415647A1 (en) | 2002-02-07 |
| DE60128569D1 (de) | 2007-07-05 |
| US20080107602A1 (en) | 2008-05-08 |
| NZ523697A (en) | 2004-12-24 |
| PT1307537E (pt) | 2007-08-30 |
| US20080107645A1 (en) | 2008-05-08 |
| AU7739001A (en) | 2002-02-13 |
| EP1307537A1 (en) | 2003-05-07 |
| US20030185852A1 (en) | 2003-10-02 |
| EP1307537A4 (en) | 2005-01-05 |
| AU2001270345A1 (en) | 2002-02-13 |
| WO2002010340A1 (en) | 2002-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60126680D1 (de) | Tragbares durchflusszytometer | |
| WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
| ATE303993T1 (de) | 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe | |
| ATE423122T1 (de) | Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri) | |
| MA27793A1 (fr) | Associations de substances actives presentant des proprietes nematicides et insecticides a base de composes trifluorobutenyle | |
| DE69835536D1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
| EP1610678A4 (en) | ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF FOR INHIBITING THE ACTIVITY OF METAL PROTEINS | |
| EP1680666A4 (en) | DETECTION OF HUMAN ANTITHERAPEUTIC ANTIBODIES | |
| BR0109002A (pt) | Receptores antagonistas il-8 | |
| EP2020445A4 (en) | DETECTION OF INFLAMMATORY DISEASE AND COMPOSITION FOR PREVENTING OR TREATING AN INFLAMMATORY DISEASE | |
| TR200003252T2 (tr) | Interleukın-1ß dönüştürme enzimi succınamıde inhibitörleri. | |
| DK1307537T3 (da) | Neospora caninum-isolat | |
| HRP20050517B1 (hr) | N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi | |
| BR0209430A (pt) | Compostos heterocìclicos | |
| BR0108867A (pt) | Antagonistas de receptor il-8 | |
| ATE365036T1 (de) | Creatinester-pronutrient-verbindungen und formulierungen | |
| BR0213574A (pt) | Compostos básicos lineares apresentando atividade antagonista do nk-2 e formulações contendo os mesmos | |
| MY137266A (en) | Acetylcholinesterase assay | |
| MA28073A1 (fr) | Elimination de pathogenes et de parasites vegetaux par le biais d'auxines appliquees ou induites | |
| BRPI0411382A (pt) | derivados de 2-aminobenzoil | |
| MA27184A1 (fr) | Dosage d'anticorps anti-ingap | |
| BR0114419A (pt) | N-alcoxialquil-substituìdo de benzimidazóis, sua preparação e seu uso como agentes contra protozoários parasìticos | |
| HK1039896A1 (zh) | 重組新孢子蟲抗原和它們的用途 | |
| BRPI0406802A (pt) | Derivados de 9-cetoespinosinas | |
| WO2002002087A3 (de) | Anthelmintika zur verhinderung von parasitären infektionen bei menschen und tieren ii |